Literature DB >> 24488318

Structural and functional in silico analysis of LRRK2 missense substitutions.

Fernando Cardona1, Marta Tormos-Pérez, Jordi Pérez-Tur.   

Abstract

The LRRK2 gene (Leucine-Rich Repeat Kinase 2, PARK8) is mutated in a significant number of cases of autosomal dominant Parkinson's disease (PD) and in some sporadic cases of late-onset PD. LRRK2 is a large, complex protein that comprises several interaction domains: armadillo, ankyrin, leucine-rich repeats and WD40 domains; two catalytic domains: ROC-GTPase and serine/threonine kinase; and a COR domain (unknown function). Pathogenic mutations are scattered all over the domains of LRRK2, although the prevalence of mutations in some domains is higher (ROC-GTPase, COR and kinase). In this work, we model the structure of each domain to predict and explore the effects of described missense mutations and polymorphisms. The results allow us to postulate the possible effects of pathogenic mutations in the function of the protein, and hypothesize the importance of some polymorphisms that have not been linked directly to PD, but act as risk factors for the disease. In our analysis, we also study the effects of PD-related mutations in the kinase domain structure and in the phosphorylation of the activation loop to determine effects on kinase activity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24488318     DOI: 10.1007/s11033-014-3111-z

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  54 in total

1.  Lrrk2 p.Q1111H substitution and Parkinson's disease in Latin America.

Authors:  Ignacio F Mata; Greggory J Wilhoite; Dora Yearout; Justin A Bacon; Mario Cornejo-Olivas; Pilar Mazzetti; Victoria Marca; Olimpio Ortega; Oscar Acosta; Carlos Cosentino; Luis Torres; Angel C Medina; Carolina Perez-Pastene; Fernando Díaz-Grez; Carles Vilariño-Güell; Pablo Venegas; Marcelo Miranda; Osvaldo Trujillo-Godoy; Luis Layson; Rodrigo Avello; Elena Dieguez; Victor Raggio; Federico Micheli; Claudia Perandones; Victoria Alvarez; Juan Segura-Aguilar; Matthew J Farrer; Cyrus P Zabetian; Owen A Ross
Journal:  Parkinsonism Relat Disord       Date:  2011-05-31       Impact factor: 4.891

2.  LRRK2 haplotype-sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation.

Authors:  Oswaldo Lorenzo-Betancor; Lluís Samaranch; Mario Ezquerra; Eduardo Tolosa; Elena Lorenzo; Jaione Irigoyen; Carles Gaig; María A Pastor; Alexandra I Soto-Ortolaza; Owen A Ross; María C Rodríguez-Oroz; Francesc Valldeoriola; María J Martí; María R Luquin; Jordi Perez-Tur; Juan A Burguera; José A Obeso; Pau Pastor
Journal:  Mov Disord       Date:  2011-10-28       Impact factor: 10.338

3.  Dyrk1A phosphorylates alpha-synuclein and enhances intracellular inclusion formation.

Authors:  Eun Joo Kim; Jee Young Sung; Hyun Jung Lee; Hyewhon Rhim; Masato Hasegawa; Takeshi Iwatsubo; Do Sik Min; Jongsun Kim; Seung R Paik; Kwang Chul Chung
Journal:  J Biol Chem       Date:  2006-09-07       Impact factor: 5.157

Review 4.  LRRK2 in Parkinson's disease: protein domains and functional insights.

Authors:  Ignacio F Mata; William J Wedemeyer; Matthew J Farrer; Julie P Taylor; Kathleen A Gallo
Journal:  Trends Neurosci       Date:  2006-04-17       Impact factor: 13.837

Review 5.  LRRK2 and neurodegeneration.

Authors:  Gabriel Santpere; Isidre Ferrer
Journal:  Acta Neuropathol       Date:  2009-01-14       Impact factor: 17.088

6.  Human non-synonymous SNPs: server and survey.

Authors:  Vasily Ramensky; Peer Bork; Shamil Sunyaev
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

7.  Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase.

Authors:  Junpeng Deng; Patrick A Lewis; Elisa Greggio; Eli Sluch; Alexandra Beilina; Mark R Cookson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-29       Impact factor: 11.205

8.  Structure of the Roc-COR domain tandem of C. tepidum, a prokaryotic homologue of the human LRRK2 Parkinson kinase.

Authors:  Katja Gotthardt; Michael Weyand; Arjan Kortholt; Peter J M Van Haastert; Alfred Wittinghofer
Journal:  EMBO J       Date:  2008-07-24       Impact factor: 11.598

Review 9.  LRRK2 in Parkinson's disease: genetic and clinical studies from patients.

Authors:  Udhaya Kumari; E K Tan
Journal:  FEBS J       Date:  2009-10-05       Impact factor: 5.542

10.  The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation.

Authors:  Elisa Greggio; Ibardo Zambrano; Alice Kaganovich; Alexandra Beilina; Jean-Marc Taymans; Veronique Daniëls; Patrick Lewis; Shushant Jain; Jinhui Ding; Ali Syed; Kelly J Thomas; Veerle Baekelandt; Mark R Cookson
Journal:  J Biol Chem       Date:  2008-04-08       Impact factor: 5.157

View more
  6 in total

Review 1.  Potential for therapeutic targeting of AKAP signaling complexes in nervous system disorders.

Authors:  Angela R Wild; Mark L Dell'Acqua
Journal:  Pharmacol Ther       Date:  2017-12-17       Impact factor: 12.310

Review 2.  Structural biology of the LRRK2 GTPase and kinase domains: implications for regulation.

Authors:  Bernd K Gilsbach; Arjan Kortholt
Journal:  Front Mol Neurosci       Date:  2014-05-05       Impact factor: 5.639

Review 3.  The role of the LRRK2 gene in Parkinsonism.

Authors:  Jie-Qiong Li; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurodegener       Date:  2014-11-12       Impact factor: 14.195

4.  GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2.

Authors:  Marian Blanca Ramírez; Antonio Jesús Lara Ordóñez; Elena Fdez; Jesús Madero-Pérez; Adriano Gonnelli; Matthieu Drouyer; Marie-Christine Chartier-Harlin; Jean-Marc Taymans; Luigi Bubacco; Elisa Greggio; Sabine Hilfiker
Journal:  Hum Mol Genet       Date:  2017-07-15       Impact factor: 6.150

5.  Association of rare variants in neurodegenerative genes with familial Alzheimer's disease.

Authors:  Weiwei Zhang; Bin Jiao; Tingting Xiao; Xixi Liu; Xinxin Liao; Xuewen Xiao; Lina Guo; Zhenhua Yuan; Xinxiang Yan; Beisha Tang; Lu Shen
Journal:  Ann Clin Transl Neurol       Date:  2020-09-17       Impact factor: 4.511

6.  A motif within the armadillo repeat of Parkinson's-linked LRRK2 interacts with FADD to hijack the extrinsic death pathway.

Authors:  Nasia Antoniou; Dimitrios Vlachakis; Anna Memou; Emmanouela Leandrou; Polytimi-Eleni Valkimadi; Katerina Melachroinou; Diane B Re; Serge Przedborski; William T Dauer; Leonidas Stefanis; Hardy J Rideout
Journal:  Sci Rep       Date:  2018-02-22       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.